Ethical and safety issues of stem cell-based therapy part 28

Stem cell 5

 

Mesenchymal stem cell-based therapy of liver diseases

Over the past few years, several clinical trials used mesenchymal stem cells to treat patients with liver diseases. Obtained results demonstrated that mesenchymal stem cells treatment improved liver function in safe and well tolerated manner. Amer and colleagues demonstrated the safety and short-term therapeutic effect of autologous transplantation of bone marrow mesenchymal stem cells-derived hepatocyte-like cells in patients with end-stage liver failure. In patients with liver failure caused by hepatitis B virus infection, autologous transplantation of bone marrow-mesenchymal stem cells provided short-term efficacy in respect to several clinical and biochemical parameters, but long-term outcomes were not markedly improved. Recent studies reported that infusion of umbilical-cord derived mesenchymal stem cells was well tolerated in patients with decompensated cirrhosis, and in patients suffering from acute on chronic liver failure, resulting in significant improvement of liver function and increased survival rates.

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s